Class of warrant or right exercisable number.

No definition available.

Name:	srne_ClassOfWarrantOrRightExercisableNumber
Namespace Prefix:	srne_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Class of warrant or right, period in which warrants can be exercised from grant date

+ References

No definition available.

+ Details

Name:	srne_ClassOfWarrantOrRightPeriodInWhichWarrantsCanBeExercisedFromGrantDate
Namespace Prefix:	srne_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Common Stock Voting Rights, Number of Shares Per Vote

+ References

No definition available.

+ Details

Name:	srne_CommonStockVotingRightsNumberofSharesPerVote
Namespace Prefix:	srne_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_AllocatedShareBasedCompensationExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(4))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.

+ References

No definition available.

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Aggregate number of common shares reserved for future issuance.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_CommonStockCapitalSharesReservedForFutureIssuance
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Unrecognized cost of unvested share-based compensation awards.

+ References

+ Details

Name:	us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

+ Details

Name:	us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Additional share-based compensation cost recognized as a result of an occurrence of an event that accelerates its recognition.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Gross number of share options (or share units) granted during the period.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of options outstanding, including both vested and non-vested options.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.D.2)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

+ Details

Name:	us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

+ Details

Name:	us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_PlanNameAxis=srne_TwoThousandFifteenStockOptionPlanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TitleOfIndividualAxis=srne_NonEmployeeConsultantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TitleOfIndividualAxis=srne_DirectorsAndNonEmployeeConsultantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=srne_TNKTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TitleOfIndividualAxis=us-gaap_ChiefExecutiveOfficerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=srne_LACellMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=srne_ConcortisBiosystemsCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=srne_ScintillaPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=srne_SorrentoBiologicsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Stockholders' Equity - 2015 Stock Option Plans (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended			12 Months Ended
	Aug. 29, 2017	Nov. 30, 2015	Oct. 31, 2015	May 31, 2015	Dec. 31, 2017	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)					32,990,232
2015 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accelerated compensation cost	$ 281
2015 Stock Incentive Plan [Member] \| Director [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation					$ 0	$ 166
Unrecognized compensation cost related to unvested stock option and warrant grants					$ 0
Period for recognized compensation cost					3 years 6 months
2015 Stock Incentive Plan [Member] \| Non-employee consultants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation					$ 156	$ 189
2015 Stock Incentive Plan [Member] \| Directors and non-employee consultants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield					0.00%
Risk-free interest rate, minimum					1.39%
Risk-free interest rate, maximum					2.24%
Expected volatility, minimum					76.00%
Expected volatility, maximum					77.00%
2015 Stock Incentive Plan [Member] \| Minimum [Member] \| Directors and non-employee consultants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life of options					4 years
2015 Stock Incentive Plan [Member] \| Maximum [Member] \| Directors and non-employee consultants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life of options					6 years 1 month 6 days
2015 Stock Incentive Plan [Member] \| TNK Therapeutics [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Granted (in shares)		500,000		3,600,000
Stock options, contractual term				10 years
Options Canceled (in shares)					1,600,000
Option outstanding (in shares)					1,400,000
Warrant shares exercisable				4,000,000
Warrant exercise price per share (USD per share)				$ 0.01
2015 Stock Incentive Plan [Member] \| TNK Therapeutics [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding options vesting anniversary period				2 years
Warrant exercisable period				40 months
2015 Stock Incentive Plan [Member] \| TNK Therapeutics [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding options vesting anniversary period				4 years
Warrant exercisable period				4 years
2015 Stock Incentive Plan [Member] \| TNK Therapeutics [Member] \| Common class A [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)				10,000,000
2015 Stock Incentive Plan [Member] \| TNK Therapeutics [Member] \| Class B [Member] \| CEO [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrant granted to purchase common stock (in shares)				9,500,000
Voting rights, number of shares per vote				10
2015 Stock Incentive Plan [Member] \| L A Cell [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Granted (in shares)				2,900,000
Stock options, contractual term				10 years
Options Canceled (in shares)					1,500,000
Option outstanding (in shares)					600,000
Warrant shares exercisable				4,000,000
Warrant exercise price per share (USD per share)				$ 0.01
2015 Stock Incentive Plan [Member] \| L A Cell [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding options vesting anniversary period				2 years
Warrant exercisable period				40 months
2015 Stock Incentive Plan [Member] \| L A Cell [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding options vesting anniversary period				4 years
Warrant exercisable period				4 years
2015 Stock Incentive Plan [Member] \| L A Cell [Member] \| Common class A [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)				10,000,000
2015 Stock Incentive Plan [Member] \| L A Cell [Member] \| Class B [Member] \| CEO [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrant granted to purchase common stock (in shares)				9,500,000
Voting rights, number of shares per vote				10
2015 Stock Incentive Plan [Member] \| Concortis Biosystems, Corp. [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Granted (in shares)			1,800,000
Stock options, contractual term			10 years
Options Canceled (in shares)					1,600,000
Option outstanding (in shares)					100,000
Warrant shares exercisable			4,000,000
Warrant exercise price per share (USD per share)			$ 0.25
2015 Stock Incentive Plan [Member] \| Concortis Biosystems, Corp. [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding options vesting anniversary period			2 years
Warrant exercisable period			40 months
2015 Stock Incentive Plan [Member] \| Concortis Biosystems, Corp. [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding options vesting anniversary period			4 years
Warrant exercisable period			4 years
2015 Stock Incentive Plan [Member] \| Concortis Biosystems, Corp. [Member] \| Common class A [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)			10,000,000
2015 Stock Incentive Plan [Member] \| Concortis Biosystems, Corp. [Member] \| Class B [Member] \| CEO [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrant granted to purchase common stock (in shares)			9,500,000
Voting rights, number of shares per vote			10
2015 Stock Incentive Plan [Member] \| Scintilla Pharmaceuticals, Inc [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, contractual term			10 years
Options Canceled (in shares)					800,000
Option outstanding (in shares)					100,000
Warrant shares exercisable			4,000,000
Warrant exercise price per share (USD per share)			$ 0.01
2015 Stock Incentive Plan [Member] \| Scintilla Pharmaceuticals, Inc [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding options vesting anniversary period			2 years
Warrant exercisable period			40 months
2015 Stock Incentive Plan [Member] \| Scintilla Pharmaceuticals, Inc [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding options vesting anniversary period			4 years
Warrant exercisable period			4 years
2015 Stock Incentive Plan [Member] \| Scintilla Pharmaceuticals, Inc [Member] \| Common class A [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)			10,000,000
Options Granted (in shares)			2,100,000
2015 Stock Incentive Plan [Member] \| Scintilla Pharmaceuticals, Inc [Member] \| Class B [Member] \| CEO [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrant granted to purchase common stock (in shares)			9,500,000
Voting rights, number of shares per vote			10
2015 Stock Incentive Plan [Member] \| Sorrento Biologics, Inc [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Granted (in shares)			2,600,000
Stock options, contractual term			10 years
Options Canceled (in shares)					1,300,000
Option outstanding (in shares)					75,000
Warrant shares exercisable			4,000,000
Warrant exercise price per share (USD per share)			$ 0.01
2015 Stock Incentive Plan [Member] \| Sorrento Biologics, Inc [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding options vesting anniversary period			2 years
Warrant exercisable period			40 months
2015 Stock Incentive Plan [Member] \| Sorrento Biologics, Inc [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding options vesting anniversary period			4 years
Warrant exercisable period			4 years
2015 Stock Incentive Plan [Member] \| Sorrento Biologics, Inc [Member] \| Common class A [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for issuance (in shares)			10,000,000
2015 Stock Incentive Plan [Member] \| Sorrento Biologics, Inc [Member] \| Class B [Member] \| CEO [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrant granted to purchase common stock (in shares)			9,500,000
Voting rights, number of shares per vote			10